ITEMS IN AFP WITH KEYWORD:
Vorapaxar should be limited to select patients with a history of MI or peripheral arterial disease who desire additional treatment for the prevention of MI.
A woman presented with gradually decreasing vision in her right eye. Retinal examination revealed intraretinal hemorrhages in the right eye with edema.
This large, adequately powered trial did not find any clinically meaningful benefit to the use of niacin in patients who are already taking a statin, even with several study design features that should bias the result in favor of niacin. Niacin should not be prescribed to reduce the risk of cardiova...
What are the effects of drug treatments for primary Raynaud phenomenon?
Aug 1, 2014 Issue
Effectiveness of Calcium Channel Blockers for Raynaud Phenomenon [Cochrane for Clinicians]
CCBs are modestly effective at reducing the frequency of attacks of primary Raynaud phenomenon. There is no evidence that attack severity or physiologic measurements are reduced by CCBs. Treatment is associated with adverse effects such as headache, flushing, and edema.
A 21-year-old man presented with fever, cough, arthralgias, and bilateral lower extremity rash and swelling that began 24 hours earlier.
Photo Quiz presents readers with a clinical challenge based on a photgraph or other image.
Ticagrelor is an alternative to clopidogrel for secondary prevention of cardiovascular death in patients with acute coronary syndrome. In an international study it was found to be more effective, but patients in the United States did not experience superior outcomes.
The ankle-brachial index (ABI) is the ratio of the systolic blood pressure at the ankle to the systolic blood pressure at the brachial artery. The American Heart Association (AHA) released a scientific statement on the measurement and interpretation of ABI, including standardization of measurement technique and the threshold for diagnosing PAD.
Jun 15, 2012 Issue
ACP Recommendations for VTE Prophylaxis in Hospitalized Patients [Practice Guidelines]
Most hospitalized patients have at least one risk factor for venous thromboembolism (VTE), such as pulmonary embolism or deep venous thrombosis. The American College of Physicians (ACP) has released guidelines on VTE prophylaxis in hospitalized, nonsurgical patients, including those with acute stroke.